CDC42 and non-small cell lung carcinoma: To date no activating CDC42 mutations have been detected in human cancer, but CDC42 has been shown to be overexpressed in many different cancer types such as breast [3, 4], testicular cancer [5], head and neck squamous cell cancer [6], melanoma [7], colorectal cancer [8], and non-small cell lung cancer [9].